More from Faculty of Medicine News


$6M grant for new Open Science patient registry

Goal is to accelerate research and let patients know how their data is helping find treatments

A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.

Published: 28 Apr 2023

Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial

Alpha Tau Medical Ltd. the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that its first patient with advanced inoperable pancreatic cancer has been treated in a feasibility and safety study of Alpha DaRT at the Jewish General Hospital (JGH) in Montreal, Canada, which is an affiliated teaching hospital of McGill University, Faculty of Medicine.

Published: 4 Apr 2023

Genes reveal kidney cancer’s risk of recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

The research, undertaken by a team of 44 researchers at 23 institutions across Europe and Canada, including McGill University, is the largest to link the genetic changes that occur in kidney cancer to patient outcomes.

Published: 23 Feb 2023

McGill researchers’ studies offer promise for lung and brain cancer treatment

Two seminal studies from McGill University, investigating immune landscapes of lung and brain tumours, were published today in Nature. This work was led by Logan Walsh, Daniela Quail and Peter Siegel, researchers at the Rosalind and Morris Goodman Cancer Institute and Philippe Joubert from Université Laval.

Email address:
Published: 2 Feb 2023

Study finds obesity-related neurodegeneration mimics Alzheimer’s disease

Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groups

A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.

Email address:
Published: 31 Jan 2023

Neuro director to co-chair new national clinical trial initiative

Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the country

Today the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr.

Published: 19 Jan 2023

Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration

Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide

A new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.

Email address:
Published: 15 Dec 2022

Message from VP-Dean Eidelman - The Faculty's Return to Campus

Dear Faculty of Medicine and Health Sciences Colleagues,

Published: 30 Jun 2021

Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada

Vancouver, BC -- The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Marathon of Hope Cancer Centres Network to begin operating.

Published: 9 Jun 2021

McGill researcher-led International Task Force unveils first-of-its kind standards for treatment of obsessive-compulsive disorder

By David McFadden

Listed by the World Health Organization among the ten leading causes of medical disability worldwide, the severity of obsessive-compulsive disorder (OCD) is at a level on par with cancer.  This prevalent disorder is characterized by highly distressing intrusive thoughts and repeated compulsive behaviours such as washing or checking.

Published: 3 Jun 2021

Two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy

A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy

Source: RI-MUHC

Published: 3 Jun 2021

Message from VP-Dean Eidelman - Planning for a return to campus

Dear members of our Faculty community,

Our world has changed since the onset of the COVID-19 pandemic, yet we have persevered to continue to offer world-class education and conduct leading research. Indeed, I am immensely proud of our contributions.

Published: 19 May 2021

Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea

Canadian Task Force on Preventive Health Care recommends routine screening

Source: CMAJ

Anyone sexually active under age 30 should be offered testing for chlamydia and gonorrhea, according to a new guideline from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal).

Published: 19 Apr 2021

Fertility Frontier: Can Transgender Women Get Uterus Transplants?

By David McFadden

It’s been nearly seven years since the world’s first successful birth after a human womb transplant. Since that medical milestone, the experimental procedure has seen such significant clinical advances that over 60 uterus transplants have been performed in women across the globe, resulting in at least 18 live births.

Published: 19 Mar 2021

Infrared imaging could help screen for COVID-19

Technology offers more accurate method to detect illness in minimally symptomatic cases


As the global COVID-19 pandemic has continued to rage across the globe, temperature recordings have been widely used as a screening tool to help detect infected individuals.

Published: 19 Mar 2021


Back to top